Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Accepts healthy volunteers Results available

Long-term Treatment of Moderate to Severe Glabellar Lines and Lateral Canthal Lines

ClinicalTrials.gov ID: NCT04225260

Public ClinicalTrials.gov record NCT04225260. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 3, 2026, 5:17 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Open-Label Study to Evaluate the Safety of QM1114-DP for the Long-term Treatment of Moderate to Severe Glabellar Lines and Lateral Canthal Lines

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a phase 3, multicenter, open-label study to evaluate the safety of QM1114-DP for the long term treatment of moderate to severe Glabellar (Frown) Lines (GL) and Lateral Canthal Lines (Crow's Feet and LCL).

Study identification

NCT ID
NCT04225260
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Galderma R&D
Industry
Enrollment
902 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 26, 2020
Primary completion
Apr 11, 2021
Completion
May 20, 2021
Last update posted
Jun 17, 2023

2020 – 2021

United States locations

U.S. sites
29
U.S. states
15
U.S. cities
25
Facility City State ZIP Site status
Total Skin and Beauty Dermatology Center, PC Birmingham Alabama 35205
Investigate MD, LLC. Scottsdale Arizona 85255
Center for Dermatology Clinical Research, Inc. Fremont California 94538
Rejuva Medical Aesthetics, LLC Los Angeles California 90025
Westside Aesthetics Los Angeles California 90025
Marcus Facial Plastic Surgery Redondo Beach California 90277
The Maas Clinic Research Center San Francisco California 94115
ArteMedica Santa Rosa California 95401
AboutSkin Research, LLC Greenwood Village Colorado 80111
Modern Dermatology PC Westport Connecticut 06880
Center for Clinical and Cosmetic Research Aventura Florida 33180
Steven Fagien, MD, PA Boca Raton Florida 33431
Susan H. Weinkle, M.D Bradenton Florida 34209
Miami Skin and Vein LLC Coral Gables Florida 33134
Mayoral Dermatology Coral Gables Florida 33143
Skin Research Institute, LLC Coral Gables Florida 33146
Research Institute of SouthEast, LLC West Palm Beach Florida 33401
Hamilton Research LLC Alpharetta Georgia 30022
Chicago Cosmetic Surgery and Dermatology, Inc Chicago Illinois 60654
Pure Dermatology, LLC Metairie Louisiana 70001
SkinCare Physicians Chestnut Hill Massachusetts 02467
Skin Laser and Surgery Specialist of NY/NJ Hackensack New Jersey 07601
Elite Aesthetic Research Cincinnati Ohio 45236
Aventiv Research, Inc. Dublin Ohio 43016
Dallas Plastic Surgery Institute Dallas Texas 75231
Center for Advanced Clinical Research Dallas Texas 75254
Austin Institute for Clinical Research, Inc. Pflugerville Texas 78660
SkinDC, PLLC Arlington Virginia 22209
EthiQ2 Research, LLC Mequon Wisconsin 53092

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04225260, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 17, 2023 · Synced Sep 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04225260 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →